Qian Zhao — York Research Database

Phone(01904) 324437
Emaildzm505york.acuk, qian.zhaoyork.acuk

If you made any changes in Pure these will be visible here soon.

2 Meeting abstract

Cost-effectiveness of zanubrutinib versus ibrutinib in adult patients with Waldenström macroglobulinemia in the United States: Health services research and quality improvement
Castillo, J. J., Yang, K., Liu, R., Wang, Y., Cohen, A., Zimmerman, T. M., Zhao, Q., van de Wetering, G., Gao, X. & Tang, B., 2021, In: Journal of Clinical Oncology. 39, Issue 15 supplement , p. e18856 1 p.
Research output: Contribution to journal › Meeting abstract
Efficacy and safety of zanubrutinib versus rituximab-based chemoimmunotherapy in Waldenström macroglobulinemia (WM): Matching-adjusted indirect comparisons: Hematologic malignancies—lymphoma and chronic lymphocytic leukemia
Castillo, J. J., Yang, K., Liu, R., Wang, Y., Cohen, A., Zimmerman, T. M., Zhao, Q., Gao, X. & Tang, B., 2021, In: Journal of Clinical Oncology. 39, 15 supplement, p. 7559 1 p.
Research output: Contribution to journal › Meeting abstract